2024 Global Summit and Award Ceremonies for Cancer Research and Entrepreneurship

AIM-HI Accelerator Fund shared a post on LinkedIn:

“Our 2024 Global Summit and Award Ceremonies for Cancer Research and Entrepreneurship will be live in 24 days!

Don’t miss this one-of-its-kind conference gathering the top minds in the oncology ecosystem where ideas are born and collaboration thrives.

Register today.

We are excited to have the following leaders join the afternoon session to showcase their promising oncology companies and innovative technologies.

1:30-3:00 pm Session I: Innovative Oncology Companies Showcase

Moderator: Matt Tremblay, Ph.D., (Chair of AIM-HI Board, and CEO of Blackbird Laboratories)
Speakers:

• Jenny Lesser Herbach, (CEO of Adventris Pharmaceuticals)
• Samir Khleif, (CEO of Georgiamune)
• Vipin Suri, (CSO of Clasp Therapeutics)
• Lily Zou, (CEO of Degron Therapeutics)
• Ronald Herbst, (CMO of Biolojic Design)

Join us on October 18, 2024, at the National Press Club in Washington, DC to celebrate innovators of the oncology field. Find out the full program details and other high-profile speakers at this exciting event here.”

Source: AIM-HI Accelerator Fund/LinkedIn